By Michael Erman Oct 7 (Reuters) – The pharmaceutical industry's top lobby group on Wednesday sued to invalidate the Trump administration's efforts to benchmark US drug prices to lower costs overseas
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
VIDEO SHOWS: ARCHIVE STILL PHOTOGRAPHS OF FORMER SWISS INTERNATIONAL DEFENDER RAMON VEGA / ARCHIVE MATERIAL…
By Jody Godoy and Doyinsola Oladipo Oct 7 (Reuters) - The US Federal Trade Commission…
PARIS, Oct 7 (Reuters) - Euronext wheat fell on Wednesday from a four-week high as…
By Diana Novak Jones Oct 7 (Reuters) - Florida asked a state judge on Wednesday…
* Fine could top $500 million, source says * FTC concerned with ads steering travelers…
VIDEO SHOWS: DAY ONE OF THE SHANGHAI MASTERS - AN ATP MASTERS 1000 TOURNAMENT SHOWS:…